Health Bulletin 04/October/2025
Here are the top health stories of the day:
Attacks on doctors threaten Lives and patient safety in Hospitals: Delhi HC Warns
While considering a criminal case against a patient's attendant who had allegedly assaulted a doctor, the Delhi High Court bench took note of the compromise entered into between the parties and held that such an act of assault upon a medical professional, apart from endangering the lives of doctors and staff, also jeopardises the treatment of other patients needing urgent care.
NMC Sets Deadline for Medical Colleges to submit NEET SS 2024 Admission details online
The Post Graduate Medical Education Board (PGMEB) has directed all medical colleges to submit information relating to admission made in Medical College/Postgraduate Institute through the National Eligibility and Entrance Test-Super Speciality (NEET SS) for the academic year 2024.
Through the letter, the Medical Colleges are required to ensure that all admissions in the SS courses are strictly in accordance with merit and are made transparently and fairly as envisaged in the Regulations. Any violation shall lead to the discharge of the concerned students from the courses and such action against the concerned Medical College/Institution as is permissible in law.
For more details, check out the full story on the link mentioned below:
NMC deadline to medical colleges to submit NEET SS 2024 admission details online
Punjab and Haryana HC criticises doctors over Illegible prescriptions
Slamming doctors for continuing to write illegible prescriptions despite access to computers, the Punjab and Haryana High Court has directed them to write in clear, bold capital letters until a comprehensive digital prescription system is established.
The court emphasised that patients have a fundamental right to receive clear and readable medical prescriptions, stressing that poor handwriting can directly impact a patient’s health and safety.
To prevent confusion, the court instructed the government to introduce handwriting training in medical curricula and to implement a nationwide digital system within two years. Until then, it directed doctors to write in bold, legible letters.
For more details, check out the full story on the link mentioned below:
Illegible Prescriptions Not Acceptable: Punjab and Haryana HC raps doctors
51 Lakh people in India are at risk of contracting Chikungunya in the Long Term: Study
India is projected to face the most significant long-term impact of chikungunya, with an estimated 51 lakh people at risk annually, according to a global modelling study published in BMJ Global Health. Brazil and Indonesia follow as the second and third most affected countries, with India and Brazil together accounting for 48% of the global healthcare and individual burden. Researchers from the London School of Hygiene and Tropical Medicine highlight chronic health effects as the major concern, with about half of those infected potentially suffering long-term disabilities.
Globally, over 1.4 crore people could be at risk yearly, predominantly children under 10 and adults over 80. Chikungunya is transmitted by Aedes mosquitoes, causing fever, severe joint pain, and in many cases, prolonged disability. With no specific treatments, two vaccines are approved in some countries, including the US. The study emphasises urgent public health preparedness and targeting vulnerable populations for vaccination to mitigate this growing threat.
REFERENCE: Kang H, Lim A, Auzenbergs M, Clark A, Colón-González FJ, Salje H, et al. Global, regional and national burden of chikungunya: force of infection mapping and spatial modelling study. BMJ Global Health. 2025;10:e018598. https://doi.org/10.1136/bmjgh-2024-018598
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.